Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis. 2018

Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
a Razi Drug Research Center , Iran University of Medical Sciences , Tehran , Iran.

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease associated with disruption of alveolar epithelial cell layer and expansion of fibroblasts/myofibroblasts. Excessive levels of oxidative/nitrosative stress, induction of apoptosis, and insufficient autophagy may be involved in IPF pathogenesis; hence, the targeting of these pathways may ameliorate IPF. Areas covered: We describe the ameliorative effect of melatonin on IPF. We summarize the research on IPF pathogenesis with a focus on oxidative/nitrosative stress, autophagy and apoptosis pathways and discuss the potential effects of melatonin on these pathways. Expert opinion: Oxidative/nitrosative stress, apoptosis and autophagy could be interesting targets for therapeutic intervention in IPF. Melatonin, as a potent antioxidant, induces the expression of antioxidant enzymes, scavenges free radicals and modulates apoptosis and autophagy pathways. The effect of melatonin in the induction of autophagy could be an important mechanism against fibrotic process in IPF lungs. Further clinical studies are necessary to determine if melatonin could be a candidate for treating IPF.

UI MeSH Term Description Entries
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073039 Nitrosative Stress A metabolic excess of REACTIVE NITROGEN SPECIES, including NITRIC OXIDE and PEROXYNITRITE, that leads to damaging effects of oxidation and nitration. Stress, Nitrosative,Nitrosative Stresses,Stresses, Nitrosative
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D054990 Idiopathic Pulmonary Fibrosis A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change. Cryptogenic Fibrosing Alveolitis,Familial Idiopathic Pulmonary Fibrosis,Fibrocystic Pulmonary Dysplasia,Fibrosing Alveolitis, Cryptogenic,Idiopathic Fibrosing Alveolitis, Chronic Form,Idiopathic Pulmonary Fibrosis, Familial,Interstitial Pneumonitis, Usual,Pulmonary Fibrosis, Idiopathic,Usual Interstitial Pneumonia,Cryptogenic Fibrosing Alveolitides,Dysplasia, Fibrocystic Pulmonary,Fibrocystic Pulmonary Dysplasias,Fibrosing Alveolitides, Cryptogenic,Idiopathic Pulmonary Fibroses,Interstitial Pneumonia, Usual,Pneumonitides, Usual Interstitial,Pneumonitis, Usual Interstitial,Pulmonary Dysplasia, Fibrocystic,Pulmonary Fibroses, Idiopathic,Usual Interstitial Pneumonias,Usual Interstitial Pneumonitides,Usual Interstitial Pneumonitis
D058628 Myofibroblasts Spindle-shaped cells with characteristic CONTRACTILE PROTEINS and structures that contribute to the WOUND HEALING process. They occur in GRANULATION TISSUE and also in pathological processes such as FIBROSIS. Myofibroblast

Related Publications

Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
September 2010, Free radical biology & medicine,
Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
January 2021, Frontiers in pharmacology,
Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
October 2017, Respiratory medicine,
Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
November 2015, American journal of respiratory cell and molecular biology,
Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
December 2023, Trends in immunology,
Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
July 1999, Free radical biology & medicine,
Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
August 2022, Heliyon,
Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
August 2022, ACS pharmacology & translational science,
Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
January 2022, Evidence-based complementary and alternative medicine : eCAM,
Azam Hosseinzadeh, and Seyed Ali Javad-Moosavi, and Russel J Reiter, and Rasoul Yarahmadi, and Habib Ghaznavi, and Saeed Mehrzadi
February 2021, Antioxidants (Basel, Switzerland),
Copied contents to your clipboard!